Time is precious when it comes to effective detection, diagnosis and treatment of breast cancer. We strive to save you time at every step along the Continuum of Care.
Designed for clinical confidence and effectiveness in treating heavy menstrual bleeding, and protecting sexual and reproductive health.
From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.
Expand your STI capabilities with Chlamydia, Gonorrhoeae, Trichomonas vaginalis, Mycoplasma genitalium and Herpes testing on full automation.
Aptima® assays offers clear, objective and qualitative results for the three most common causes of vaginitis, Bacterial vaginosis, Candida vaginitis and Trichomoniasis.
A single, patient friendly exam generates high-resolution images to accurately assess bone density, fracture risk and body composition.
Superior positioning, enhanced imaging and easy handling for extremities imaging to meet the demands of today’s surgeons.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient result to population level screening.
From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient result to population level screening.
From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.
From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.
From HPV to cytology, and now also AI based digital diagnostics, we offer a comprehensive screening portfolio, from sample collection to diagnosis.
A scalable portfolio combining a broad, high performing assay menu with high throughput automation, from a single patient result to population level screening.
Developed for highly accurate results and simplified workflow, collection devices that support a comprehensive testing portfolio for women's health and infectious disease.
Cervical sample collection and preservation, with more than 1 billion vials used worldwide for cervical cancer screening.
For more End of Life documents, please visit our global End of Life documents page.